Back
Zevra Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
9.49
Seasonality Move:
6.65%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing selling pressure, which indicates risk of future bearish movement.
Zevra Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.1 | Buy |
| 20-day SMA: | 8.84 | Buy |
| 50-day SMA: | 8.26 | Buy |
| 200-day SMA: | 6.39 | Buy |
| 8-day EMA: | 9.2 | Buy |
| 20-day EMA: | 8.88 | Buy |
| 50-day EMA: | 8.33 | Buy |
| 200-day EMA: | 6.82 | Buy |
Zevra Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 63.79 | Buy |
| Chaikin Money Flow: | -210557 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.19 - 9.15) | Buy |
| Bollinger Bands (100): | (6.61 - 8.53) | Buy |
Zevra Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
- Zevra Therapeutics share price is 9.43 while ZVRA 8-day simple moving average is 9.10, which is a Buy signal.
- The stock price of ZVRA is 9.43 while Zevra Therapeutics 20-day SMA is 8.84, which makes it a Buy.
- Zevra Therapeutics 50-day simple moving average is 8.26 while ZVRA share price is 9.43, making it a Buy technically.
- ZVRA stock price is 9.43 and Zevra Therapeutics 200-day simple moving average is 6.39, creating a Buy signal.
ZVRA Technical Analysis vs Fundamental Analysis
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a Buy
The current Zevra Therapeutics [ZVRA] share price is $9.43. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
503.33M
Price in USD:
9.43
Share Volume:
402.33K
Zevra Therapeutics 52-Week Range
52-Week High:
9.76
52-Week Low:
4.20
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?
The Zevra Therapeutics stock price is 9.43 USD today. -
Will ZVRA stock go up or go down?
Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Zevra Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is not overvalued.
Is Zevra Therapeutics Stock a Buy?
- Zevra Therapeutics share price is 9.43 while ZVRA 8-day exponential moving average is 9.20, which is a Buy signal.
- The stock price of ZVRA is 9.43 while Zevra Therapeutics 20-day EMA is 8.88, which makes it a Buy.
- Zevra Therapeutics 50-day exponential moving average is 8.33 while ZVRA share price is 9.43, making it a Buy technically.
- ZVRA stock price is 9.43 and Zevra Therapeutics 200-day simple moving average is 6.82, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
- ZVRA Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Zevra Therapeutics is a Buy
- Zevra Therapeutics Relative Strength Index (RSI) is 63.79, which suggest Zevra Therapeutics is overbought
- The Bollinger Bands (25) for Zevra Therapeutics is (8.19 - 9.15), which suggest Zevra Therapeutics is a Buy
- The Bollinger Bands (100) for Zevra Therapeutics is (6.61 - 8.53), which suggest Zevra Therapeutics is a Buy
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.